234 related articles for article (PubMed ID: 12640682)
41. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
42. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
Chen YW; Jeng YM; Yeh SH; Chen PJ
Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
[TBL] [Abstract][Full Text] [Related]
43. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
44. [A preliminary study of loss of heterozygosity on chromosome 1p in primary hepatocellular carcinoma].
Shao J; Li H; Liew CT; Wu Q; Liang X; Hou J
Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):28-30. PubMed ID: 11869508
[TBL] [Abstract][Full Text] [Related]
45. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
46. Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma.
Elmileik H; Paterson AC; Kew MC
J Surg Oncol; 2005 Sep; 91(4):258-63. PubMed ID: 16121349
[TBL] [Abstract][Full Text] [Related]
47. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
48. Allelic alterations in nontumorous liver tissues and corresponding hepatocellular carcinomas from chinese patients.
Ho MK; Lee JM; Chan CK; Ng IO
Hum Pathol; 2003 Jul; 34(7):699-705. PubMed ID: 12874766
[TBL] [Abstract][Full Text] [Related]
49. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
[TBL] [Abstract][Full Text] [Related]
50. [Study on molecular basis of carcinogenesis of hepatitis B virus].
Zhu MH; Zhu Z; Liu XH; Lin J; Qu JH; Chen Y; Cao XZ; Wang L; Ni CR
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):637-8. PubMed ID: 20079199
[No Abstract] [Full Text] [Related]
51. Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C-related cirrhosis with occult hepatocellular carcinoma: a case report.
Nelson AC; Jessurun J; Peterson RK; Pambuccian SE
Liver Transpl; 2012 May; 18(5):612-4. PubMed ID: 22344889
[No Abstract] [Full Text] [Related]
52. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
53. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
[TBL] [Abstract][Full Text] [Related]
54. Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.
Nishida N; Nishimura T; Nagasaka T; Ikai I; Goel A; Boland CR
Cancer Res; 2007 May; 67(10):4586-94. PubMed ID: 17510384
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Zhang SH; Cong WM; Xian ZH; Wu MC
World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
[TBL] [Abstract][Full Text] [Related]
56. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
[TBL] [Abstract][Full Text] [Related]
57. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Calvisi DF; Factor VM; Ladu S; Conner EA; Thorgeirsson SS
Gastroenterology; 2004 May; 126(5):1374-86. PubMed ID: 15131798
[TBL] [Abstract][Full Text] [Related]
58. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
59. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
60. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]